Anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with COVID-19

Detalles Bibliográficos
Autores principales: Sofia, Rosaria, Carbone, Mattias, Landoni, Giovanni, Zangrillo, Alberto, Dagna, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Federation of Internal Medicine. Published by Elsevier B.V. 2022
Materias:
Clinical Insights
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005384/
https://www.ncbi.nlm.nih.gov/pubmed/35487806
http://dx.doi.org/10.1016/j.ejim.2022.04.009
_version_ 1784686447982280704
author Sofia, Rosaria
Carbone, Mattias
Landoni, Giovanni
Zangrillo, Alberto
Dagna, Lorenzo
author_facet Sofia, Rosaria
Carbone, Mattias
Landoni, Giovanni
Zangrillo, Alberto
Dagna, Lorenzo
author_sort Sofia, Rosaria
collection PubMed
description
format Online
Article
Text
id pubmed-9005384
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Federation of Internal Medicine. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-90053842022-04-13 Anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with COVID-19 Sofia, Rosaria Carbone, Mattias Landoni, Giovanni Zangrillo, Alberto Dagna, Lorenzo Eur J Intern Med Clinical Insights European Federation of Internal Medicine. Published by Elsevier B.V. 2022-06 2022-04-13 /pmc/articles/PMC9005384/ /pubmed/35487806 http://dx.doi.org/10.1016/j.ejim.2022.04.009 Text en © 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Clinical Insights
Sofia, Rosaria
Carbone, Mattias
Landoni, Giovanni
Zangrillo, Alberto
Dagna, Lorenzo
Anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with COVID-19
title Anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with COVID-19
title_full Anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with COVID-19
title_fullStr Anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with COVID-19
title_full_unstemmed Anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with COVID-19
title_short Anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with COVID-19
title_sort anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with covid-19
topic Clinical Insights
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005384/
https://www.ncbi.nlm.nih.gov/pubmed/35487806
http://dx.doi.org/10.1016/j.ejim.2022.04.009
work_keys_str_mv AT sofiarosaria anticoagulationassecondarypreventionofmassivelungthrombosesinhospitalizedpatientswithcovid19
AT carbonemattias anticoagulationassecondarypreventionofmassivelungthrombosesinhospitalizedpatientswithcovid19
AT landonigiovanni anticoagulationassecondarypreventionofmassivelungthrombosesinhospitalizedpatientswithcovid19
AT zangrilloalberto anticoagulationassecondarypreventionofmassivelungthrombosesinhospitalizedpatientswithcovid19
AT dagnalorenzo anticoagulationassecondarypreventionofmassivelungthrombosesinhospitalizedpatientswithcovid19

Ejemplares similares